Sero-prevalence of HBV and HCV in chronic liver disease patients - Girma, Abel;Gebre-Silassie, Solomon
32,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 6-10 Tagen
  • Broschiertes Buch

Hepatitis B and C viruses (HBV & HCV) are hepatotropic viruses causing viral hepatitis, chronic liver disease and hepatocellular carcinoma. Hepatitis B and C virus infections are still major public health problems around the globe. Both of these viruses are transmitted mainly through the parenteral route and therefore a dual infection of these viruses can occur and even persists in the same patient. They are prevalent in different parts of the world including Ethiopia. In view of this, hospital based cross-sectional study was conducted in three public hospitals of Addis Ababa over a period of…mehr

Andere Kunden interessierten sich auch für
Produktbeschreibung
Hepatitis B and C viruses (HBV & HCV) are hepatotropic viruses causing viral hepatitis, chronic liver disease and hepatocellular carcinoma. Hepatitis B and C virus infections are still major public health problems around the globe. Both of these viruses are transmitted mainly through the parenteral route and therefore a dual infection of these viruses can occur and even persists in the same patient. They are prevalent in different parts of the world including Ethiopia. In view of this, hospital based cross-sectional study was conducted in three public hospitals of Addis Ababa over a period of 7 months (Nov 2010- May 2011) on clinically diagnosed chronic liver disease patients. Serum samples from each volunteering patients was screened for the presence of HBsAg and anti-HCV Ab.
Autorenporträt
Abel Girma is PhD candidate of Environmental Engineering  at Donghua University. Abel received the Faculty of Agriculture award for contribution to the advancement of teaching and research  in the year 2014. Abel holds an MSc degree in Environmental Science form Abeba University Ethiopia, in the year 2013 and a BSc degree in Plant Science form AMU.